Aortic stenosis in the elderly: What to monitor, when and how to treat? The place of TAVI;La sténose aortique du sujet âgé: Que surveiller, quand et comment intervenir? La place du TAVI

Revue Medicale de Bruxelles

Volumn 33, Issue 4, 2012, Pages 283-290

  Lalmand, J ^a   Lalmand, M ^b  

^a Centre Hospitalier Universitaire de Charleroi   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Aortic stenosis; Aortic valve replacement; Transcatheter aortic valve replacement

Indexed keywords

AORTA STENOSIS; ARTICLE; ELDERLY CARE; HUMAN; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGE OF ONSET; AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC CATHETERS; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MONITORING, PHYSIOLOGIC; TIME FACTORS;

EID: 84867538770     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Soler-Soler J, Galve E : Worldwide perspective of valve disease. Heart 2000; 83 : 721-5 (Pubitemid 30345988)
2. Iung B, Baron G, Butchart EG et al. : A prospective survey of patients with valvular heart disease in Europe : the Euro Heart Survey on valvular heart disease. Eur Heart J 2003; 24 : 1231-43 (Pubitemid 36834640)
3. Mohler ER III : Mechanisms of aortic valve calcification. Am J Cardiol 2004; 94 : 1396-400
4. Bellamy MF, Pellikka PA, Klarich KW, Tajik AJ, Enriquez-Sarano M : Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 2002; 40 : 1723-30 (Pubitemid 35341948)
5. Rosenhek R, Rader F, Loho N et al. : Statins but not angiotensin- converting enzyme inhibitors delay progression of aortic stenosis. Circulation 2004; 110 : 1291-5 (Pubitemid 39202347)
6. O'Brien KD, Probstfield JL, Caulfield MT et al. : Angiotensin-converting enzyme inhibitors and change in aortic valve calcium. Arch Intern Med 2005; 165 : 858-62 (Pubitemid 40563231)
7. Cowell SJ, Newby DE, Prescott RJ et al. : Aortic Stenosis Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005; 352 : 2389-97
8. Vahanian A, Iung B, Pierard L, Dion R, Pepper J : Valvular heart disease. In : Camm AJ, Luscher TF, Serruys PW, eds. The ESC Textbook of Cardiovascular Medicine. Maiden/Oxford/Victoria, Blackwell Publishing Ltd 2006 : 625-70
9. Vahanian A, Baumgartner H, Bax J et al. : Guidelines on the management of valvular heart disease. The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007 ; 28 : 230-68. doi:10.1093/ eurheartj/ehl428
10. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA, for the Doppler Quantification Task Force of the Nomenclature Standards Committee of the American Society of Echocardiography : Recommendations for quantification of Doppler echocardiography : a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002; 15 : 167-84
11. De Filippi CR, Willett DL, Brickner ME et al. : Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am J Cardiol 1995; 75 : 191-4
12. Monin JL, Quere JP, Monchi M et al. : Low-gradient aortic stenosis, operative risk stratification and predictors for long-term outcome : a multicenter study using dobutamine stress hemodynamics. Circulation 2003; 108 : 319-24 (Pubitemid 36899023)
13. Nishimura RA, Grantham JA, Connolly HM, Schaff HV, Higano ST, Holmes DR Jr : Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function : the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation 2002; 106 : 809-13
14. Amato MC, Moffa PJ, Werner KE, Ramires JA : Treatment decision in asymptomatic aortic valve stenosis : role of exercise testing. Heart 2001; 86 : 381-6 (Pubitemid 32889370)
15. Das P, Rimington H, Chambers J : Exercise testing to stratify risk in aortic stenosis. Eur Heart J 2005; 26 : 1309-13 (Pubitemid 41435462)
16. Bergler-Klein J, Klaar U, Heger M et al. : Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004; 109 : 2302-8 (Pubitemid 38678520)
17. Omran H, Schmidt H, Hackenbroch M et al. : Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis : a prospective, randomised study. Lancet 2003; 361 : 1241-6 (Pubitemid 36428577)
18. Otto CM, Burwash IG, Legget ME et al. : Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997; 95 : 2262-70 (Pubitemid 27191003)
19. Rosenhek R, Binder T, Porenta G et al. : Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000; 343 : 611-7 (Pubitemid 30659472)
20. Pellikka PA, Sarano ME, Nishimura RA et al. : Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005; 111 : 3290-5 (Pubitemid 40875002)
21. Carabello BA : Evaluation and Management of Patients With Aortic Stenosis. Circulation 2002; 105 : 1746-50
22. Ross J Jr, Braunwald E : Aortic stenosis. Circulation 1968; 38 (Suppl 5) : V-61. Abstract
23. Lund O, Nielsen TT, Emmertsen K et al. : Mortality and worsening of prognostic profile during waiting time for valve replacement in aortic stenosis. Thorac Cardiovasc Surg 1996; 44 : 289-95 (Pubitemid 27032234)
24. Stewart BF, Siscovick D, Lind BK et a;. : Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997; 29 : 630-4 (Pubitemid 27116107)
25. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS : Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999; 341 : 142-7 (Pubitemid 29325741)
26. STS national database : STS U.S. cardiac surgery database : 1997 Aortic valve replacement patients : preoperative risk variables. Chicago, Society of Thoracic Surgeons, 2000. Accessed 10 May 2006. http://www.ctsnet.org/doc/3031
27. National Adult Cardiac Surgical Database Report 1999-2000. The United Kingdom Cardiac Surgical Register. Accessed 10 May 2006. http://www.scts.org/ file/NACSDreport2000ukcsr.pdf
28. O'Brien SM, Shahian DM, Filardo G et al. : The Society of Thoracic Surgeons 2008 cardiac surgery risk models : part 2 isolated valve surgery. Ann Thorac Surg 2009; 88 : S23
29. Kvidal P, Bergstrom R, Horte LG, Stahle E : Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 2000; 35 : 747-56 (Pubitemid 30167033)
30. Pibarot P, Dumesnil JG : Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention. J Am Coll Cardiol 2000; 36 : 1131-41
31. Bonow RO, Carabello BA, Chatterjee K et al. : ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists. J Am Coll Cardiol 2006; 48 : e1-e148 (Pubitemid 44109952)
32. Iung B, Gohlke-Barwolf C, Tornos P et al. : Working Group on Valvular Heart Disease. Recommendations on the management of the asymptomatic patient with valvular heart disease. Working Group Report on behalf of the Working Group on Valvular Heart Disease. Eur Heart J 2002; 23 : 1253-66
33. Otto CM : Timing of aortic valve surgery. Heart 2000; 84 : 211-8
34. Pereira JJ, Balaban K, Lauer MS, Lytle B, Thomas JD, Garcia MJ : Aortic valve replacement in patients with mild or moderate aortic stenosis and coronary bypass surgery. Am J Med 2005; 118 : 735-42 (Pubitemid 40897659)
35. Edwards MB, Taylor KM : Outcomes in nanogenarians after valve replacement operation. Ann Thorac Surg 2003; 75 : 830-4
36. Lund O, Bland M : Age and risk corrected impact of mechanical versus biological valves on long-term mortality after aortic valve replacement. J Thorac Cardiovasc Surg 2006; 132 : 20-6
37. Vahanian A, Palacios IF : Percutaneous approaches to valvular disease. Circulation 2004; 109 : 1572-9 (Pubitemid 38451711)
38. Cribier A, Eltchaninoff H, Bashet A et al. : Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis : First Human Case Description. Circulation 2002; 106 : 3006-8 (Pubitemid 35440280)
39. Holmes DR Jr, Mack MJ, Kaul S et al. : 2012 ACCF/AATS/SCAI/ STS Expert Consensus Document on Transcatheter Aortic Valve Replacement. J Am Coll Cardiol 2012; 59 : 1200-54. Epub 2012 Jan 31
40. Thomas M, Schymik G, Walther T et al. : Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registra : A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010; 122 : 62
41. Bauer F, Lemercier M, Zajarias A et al. : Immediate and long-term echocardiographic findings after transcatheter aortic valve implantation for the treatment of aortic stenosis : the Cribier-Edwards/Edwards-Sapien valve experience. J Am Soc Echocardiogr 2010; 23 : 370
42. Piazza N, Grube E, Gerckens U et al. : Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system : results from the multicentre, expanded evaluation registry 1-year following CE mark approval. Euro Intervention 2008; 4 : 242
43. Wendler O, Walther T, Nataf P et al. : Transapical aortic valve implantation : univariate and multivariate analyses of the early results from the SOURCE registry. Eur J Cardiothorac Surg 2010; 38 : 119
44. Walther T, Schuler G, Borger MA et al. : Transapical aortic valve implantation in 100 consecutive patients : comparison to propensity-matched conventional aortic valve replacement. Eur Heart J 2010; 31 : 1398
45. Rodés-Cabau J, Webb JG, Cheung A et al. : Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk : acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010; 55 : 1080
46. Leon MB, Smith CR, Mack M et al. : Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363 : 1597
47. Makkar RR, Fontana GP, Jilaihawi H et al. : Transcatheter Aortic-Valve Replacement for Inoperable Severe Aortic Stenosis. N Engl J Med 2012; 366 : 1696-704
48. Smith CR, Leon MB, Mack MJ et al. : Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364 : 2187
49. Kodali SK, Williams MR, Smith CR et al. : Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement. N Engl J Med 2012; 366 : 1686-95
50. Reynolds MR, Magnuson EA, Wang K et al. : Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis : results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation 2012; 125 : 1102-9. Epub 2012 Feb 3
51. Reynolds MR : Cost Effectiveness of Transcatheter Aortic Valve Replacement Compared With Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis : Results from The PARTNER Trial (Cohort A) - TCT 2011. San Francisco, November 7, 2011 http://www.Escardio.org http://circ.ahajournals. org